AWS for Industries

Tag: pharma

DRAGEN reanalysis of the 1000 Genomes Dataset now available on the Registry of Open Data

Guest authored by Bryan Lajoie, Staff Bioinformatics Scientist at Illumina Inc. — We are pleased to announce the release of a comprehensive reanalysis of 3,202 deeply-sequenced samples from the 1000 Genomes Project(1kGP) using the Illumina DRAGEN (Dynamic Read Analysis for GENomics) Bio-IT platform. This seminal dataset will be freely available for researchers across the world to use […]

Read More

Conducting end-to-end pharmacovigilance workflows using AWS technologies

Introduction Bio-pharmaceutical companies have always had a responsibility to report adverse events (AE), whether in clinical development or post market-approval scenarios, to the Food and Drug Administration (FDA).  The COVID-19 pandemic and the race to find effective treatments for this disease has caused both the FDA and bio-pharmaceutical organizations around the world to re-imagine the […]

Read More

Approving AWS services for GxP workloads

In this blog post, we describe the first step of a process for qualifying AWS services for use as part of GxP workloads, sometimes referred to in the industry as “whitelisting” services. AWS customers with GxP compliance requirements might want to control access to the AWS services their developers use. During the supplier assessment of […]

Read More

Building Amazon Neptune based MedDRA terminology mapping for pharmacovigilance and adverse event reporting

Life Science companies are witnessing substantial growth in number of Adverse Events (AE) being reported for their products. This may be due to the increase in data volumes coming from journals, articles, social media, and non-standardized data sources. Evolving regulations and increasing pressure to improve quality and patient safety, while maintaining patient privacy rights, and […]

Read More

Automating the Installation Qualification (IQ) Step to Expedite GxP Compliance

Good practice (GxP) guidelines were established by the Food and Drug Administration (FDA) and aim to ensure organizations working in life sciences develop, manufacture, and distribute products that are safe, meet quality guidelines, and are fit for use. GxP compliance has been a part of the life sciences industry for many years and heavily influences […]

Read More

Sanofi Webinar: Performing end-to-end real-world evidence generation with traceability and transparency on AWS

Gaining insights and knowledge from real-world health data (RWD), i.e., data acquired outside the context of randomized clinical trials, has been an area of continued opportunity for pharma organizations. In this webinar, you will hear about Sanofi’s journey and experience in building an industrialized big data & analytics platform in the cloud that handles billions […]

Read More

Webinar: Digital Medicine 101

Technology is changing how we practice medicine. Sensors and wearables are getting smaller and cheaper, and algorithms are becoming powerful enough to predict medical outcomes. Yet despite rapid advances, healthcare lags behind other industries in truly putting these technologies to use. A major barrier to entry is the cross-disciplinary approach required to create such tools, […]

Read More

Moderna Webinar: Building the Digital Biotech Company

Moderna is advancing messenger RNA (mRNA) science to create a new class of mRNA medicines designed to direct the patient’s own cells to produce proteins that have a therapeutic or preventive benefit. Developing therapeutics and vaccines for a variety of diseases challenges process development and operations to establish agile and flexible manufacturing, capable of executing […]

Read More